Miltenyi Biotec

We're at SITC 2024! Visit us at booth #425 to... 🤝 Chat with our experts about how we can support your cancer immunotherapy research. We're here to help you overcome your challenges and find tailored solutions. 🍽️ Join our lunch symposium on November 8 to explore how spatial biology is revolutionizing immunotherapy and driving next-gen CAR T cell therapies. 🎁 Enter our raffle and complete your happy cell collection! For more info, check out our dedicated page: https://ow.ly/4KHy50U23XM #SITC2024 #CancerImmunotherapy #MiltenyiBiotec #SpatialBiology

Curious about mapping the cellular landscape with spatial biology? 🗺️ Well, Marie Laviron and the team at VIB-UGent did just that! They used our MACSima™ Platform to build the Liver Cell Atlas. By combining RNA and protein analysis on the same tissue section, they were able to achieve accurate cell segmentation and identify origin cells for activation markers with unprecedented precision. Want to explore this spatial adventure? ▶️ Watch this webinar: https://ow.ly/ih9850U14pS or read this article! 👇

We are pleased to announce the release of the new CliniMACS Prodigy® LP-34-(320) System. This new process enables the reliable enrichment of CD34⁺ stem cells from mobilized leukapheresis products with high purity and yield. Check our new application sheet for basic information on the process and excellent performance data.

Great things happen when collaboration meets a shared purpose! For Dr. Austin Bigley and his team at Indapta Therapeutics, NK cells are at the core of their mission. Focusing on developing ex vivo NK cell expansion protocols to produce clinical-grade NK-cell products for cancer and antiviral immunotherapy, we proudly support Austin and his team with our NK MACS® Media, among other solutions, to help create a lasting impact. Take a look into the lab at Indapta Therapeutics and others in the field as we celebrate 35 years of Miltenyi Biotec: https://ow.ly/s7FO50TVwrr #MiltenyiBiotec35Years

🚀 We’re heading to SITC 2024! 🚀 Join us November 6–10 in Houston, TX, at the 39th SITC Annual Meeting – the must-attend event for cancer immunotherapy breakthroughs! 🧬 🗓️ Mark your calendars for November 8 and don’t miss our lunch symposium where we’ll dive into how spatial biology is shaping the future of cancer treatment. From exploring immune cell interactions to advancing personalized CAR T cell therapies – we're bringing cutting-edge tools to accelerate your research. We can’t wait to connect with fellow scientists, clinicians, and innovators who share our mission to improve cancer patient outcomes. See you in Houston! 👋 Check out more details and plan your visit here: 👉 https://ow.ly/xFH650TSE9h #MiltenyiBiotec #SpatialBiology #SITC24

Ciao, Roma! The ESGCT 2024 was a powerful reminder of the value that in-person events bring to the cell and gene therapy community. This year’s meeting provided not only a platform for sharing groundbreaking research and industry insights but also an invaluable space for reconnecting with friends and colleagues. The collaborative spirit was inspiring, with hands-on demos and lively discussions sparking new ideas and partnerships. Looking forward to seeing everyone again next year! #ESGCT2024 #cellandgenetherapy

It’s nearly the end of our 5-week adventure with Miltenyi Biotec’s: Play for Science! Have you collected all the pieces of the secret password? Don’t worry – there’s still time to catch up and get your hands on an antibody panel of your choice or a travel voucher to a conference! Test your science skills, and you could walk away with a cellsational reward! Ready to play? Let’s see what you’ve got! https://ow.ly/CuPS50TyxX0 🧠⚡ #ScienceAdventure #MiltenyiBiotec #35YearsOfInnovation #MiltenyiBiotec35Years

If you’d like to see the latest advances on organoid models and 3D imaging for Parkinson’s disease (PD) research, don’t miss out on this opportunity! Join our webinar where Prof. Schwamborn and Dr. Rodríguez-Gatica will discuss using PSC-derived midbrain-striatal assembloids and a 3D light sheet microscopy workflow, highlighting their value not only to elucidate pathomechanisms related to PD, but also to accelerate the discovery of potential therapeutics. Learn how these new approaches overcome hurdles associated with traditional PD models and confocal microscopy. Sign up here: https://ow.ly/Agfk50TOgFP

Prof. Dr. Martin Guilliams and his team from the VIB Center for Inflammation Research at the University of Ghent, Belgium, focus on the functional specialization of mouse and human liver macrophages, their microenvironment, and how these interactions change — all supported by the MACSima™ Platform. Our dual focus on uncovering complex cellular interactions and diving deep into the microenvironment shows the importance of collaboration and looking to the future. Follow up on the VIB Center's story and others in the field as we celebrate 35 years of Miltenyi Biotec: https://ow.ly/6ryN50TqSWf #MiltenyiBiotec35Years

What an event to come together and discuss the bigger questions and future trajectory of providing patients with effective cell and gene therapies — empower cells, empower lives. Thank you to all for contributing recently to the success of the Miltenyi Cell and Gene Therapy Summit 2024: where academic innovation meets industry expertise in Bergisch Gladbach, Germany. With vibrant talks on the complex ecosystem of the cellular therapy world, panel discussions, and more, thank you to the global attendees for contributing to such an inspiring event. To stay updated on the latest industry developments, case studies, and future events, feel free to sign up to our newsletter here: https://ow.ly/Nfvg50TSwsE #MiltenyiCGTSummit